Diffusion Pharmaceutical LLC
  • Email
  • Facebook
  • Twitter
  • Rss
  • Home
  • About
    • Introduction
    • Executive Summary
    • Management
    • Board of Directors
    • Investors
      • Investor Information Log-In
      • Potential Investor Registration
    • Intellectual Property
    • Useful Links
  • Cancer Treatment
    • Overview/The Problem
    • Treatment Resistance in Cancer
    • Tumor Sensitization and TSC
    • Preclinical Results
  • Clinical Trials
    • Clinical Trials Overview
  • Publications
    • Cancer
    • Cardiovascular and Stroke
    • Hemorrhagic Shock
    • Other
  • Programs
    • Program Overview
    • Glioblastoma Program
    • Brain Metastasis Program
    • Other Indications For TSC
  • News
    • Press Releases
    • Subscribe
  • Contact
    • Contact
    • Directions

Publications

  • Cancer
  • Cardiovascular and Stroke
  • Hemorrhagic Shock
  • Other

Cancer

Sheehan J, Popp B, Monteith S, Toulmin A, Tomlinson J, Martin J, Cifarelli C, Lee DH, Park D. Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor: Laboratory investigation. J Neurosurg. 2011; 115:749-753.

Sheehan J, Cifarelli C, Dassoulas K, Olson C, Rainey J, Han S. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide:  Laboratory investigation. J Neurosurg. 2010; 113:234-239.

Sheehan J, Sherman J, Jagannathan J, Dassoulas K, Cifarelli C Olson C, Rainey J, Han S. Effect of trans sodium crocetinate on brain tumor oxygenation: Laboratory investigation. J Neurosurg. 2009; 111:226–229.

Sheehan J, Ionescu A, Pouratian N, Hamilton DK, Schlesinger D, Oskouian RJ, Sansur C. Trans sodium crocetinate sensitizes glioblastoma multiforme tumors to radiation. J Neurosurg. 2008; 108:972-978.

  • Office: 434-220-0718
  • Contact Us
    • Facebook
    • Email
© 2012 Diffusion Pharmaceutical LLC


Charlottesville SEO